Arcus Biosciences, Inc. (RCUS) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to loss of $0.94 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.54%. A quarter ago, it was expected that this company would post a loss of $1.02 per share when it actually produced a loss of $1.02, delivering no surprise.Over the last four quarters, the company has surpassed con ...